Over-the-Counter Retail Naloxone Sales
First-year US OTC naloxone sales were low, peaking then stabilizing far below pharmacy or program distribution rates. High prices and limited uptake suggest OTC access has not filled distribution gaps; further research on demand drivers is needed.